About one-quarter of men with cystic fibrosis (CF) have low testosterone levels, according to a new study that sought…
Articles by Andrea Lobo, PhD
Treatment with Kalydeco (ivacaftor) for almost eight years consistently improved lung function and reduced mortality in people with…
In a real-world study involving children with cystic fibrosis (CF) in Italy, …
Danish children with cystic fibrosis (CF) born between 2000 and 2022 showed noticeable gains in growth during their first…
Levels of fat-soluble vitamins D and E and of the micronutrients zinc and selenium are generally within the normal range…
Extended treatment with Kaftrio progressively increases the diversity of the microorganisms in the gut in people with cystic…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to SPL84, an experimental inhalation therapy for people…
Improvements in mucus clearance with the approved medication Trikafta — evident among patients within a month after starting treatment,…
Four years after the approval of Trikafta (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis (CF), global disparities in access to the…
A history of pancreatic inflammation, diabetes, high blood pressure, and high cholesterol may increase the risk of pancreatic cancer in…